Widening Aims and Giving Patients a Voice for Expanded Structures in Breast Cancer Care Jointly Developed by Patients and Physicians (WAVES)
Widening Aims and Giving Patients a Voice for Expanded Structures in Breast Cancer Care Jointly Developed by Patients and Physicians (Wechselseitiger Patienten-Arzt-Austausch in Der Versorgung Bei Brustkrebs Mit Dem Ziel Der Gemeinsamen Erarbeitung Neuer Patienten-orientierter Strukturen)
The aim of this BZKF project is to record the current care structure for breast cancer patients in order to use this as a basis for developing possible future models for improvement. The active involvement of representatives of regional and national patient organizations in the creation of a patient-based and patient-oriented survey ensures that the needs of patients are the focus. In addition to and in contrast to other projects, relevant questions are explicitly addressed not only to patients but also to physicians in order to identify and specify the interfaces between patient wishes/suggestions and to develop clinical consequences for care.
The first objective is to survey the "current situation" by recording the current care structure for breast cancer. The focus is on the survey of both groups on patient-physician communication, time management and coping strategies.
By planning the future harmonization of national data structures, the basis is created for the long-term goal of an improved "target", a concept developed jointly by physicians and patients for an improved communication and care structure that focuses on the patient.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Nina Ditsch, Prof.
- Phone Number: +49 821 400 15809
- Email: nina.ditsch@uk-augsburg.de
Study Contact Backup
- Name: Melitta Köpke, Dr.
- Phone Number: +49 821 400 165862
- Email: melitta.koepke@uk-augsburg.de
Study Locations
-
-
Bavaria
-
Augsburg, Bavaria, Germany, 86156
- Recruiting
- University Hospital Augsburg, Department of Gynecology and Obstetrics
-
Contact:
- Melitta Köpke, Dr.
- Phone Number: +49 821 400 165862
- Email: melitta.koepke@uk-augsburg.de
-
Contact:
- Nina Ditsch, Prof.
- Phone Number: +49 821 400 165809
- Email: nina.ditsch@uk-agsburg.de
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria (patients):
- Breast cancer or DCIS
- women and men aged 18 years and older
Exclusion Criteria (patients):
- women and men < 18 years
- no histologically confirmed breast cancer or DCIS diagnosis
Inclusion Criteria (physicians):
- Treatment of breast cancer patients
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
BC Patients
Patients with diagnosis of breast cancer or DCIS
|
Completion of a two-part questionnaire with a special focus on communication around the breast cancer diagnosis.
Tumor stage and therapies received are also surveyed.
The questionnaire can be answered online via a secure tool (REDCap) or in paper form.
|
|
Physicians
Physicians treating patients with breast cancer
|
Completion of a questionnaire with a special focus on communication around the breast cancer diagnosis
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Current state of care - patient view
Time Frame: through study completion, an average of 3 years
|
The primary aim of the questionnaire is to record the current reality of care for breast cancer patients with a focus on communication.
|
through study completion, an average of 3 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Current state of care - physician view
Time Frame: through study completion, an average of 3 years
|
Secondarily, a comparison will be made with the physicians assessment of the same topics
|
through study completion, an average of 3 years
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Nina Ditsch, Prof., University Hospital Augsburg
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2.0
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.